Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs Withings ECG App

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
Withings ECG App
by Withings

AI Verdict

Tool A is designed for acute clinical settings, using machine learning to predict hypotensive events and provide hemodynamic insights to clinicians. In contrast, Tool B is a consumer-grade wearable app for personal health monitoring, focusing on detecting atrial fibrillation and other heart rate anomalies via single-lead ECG for over-the-counter use. While both leverage AI in cardiology, their primary applications, target users, and deployment environments are distinct.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your clinical team requires real-time, predictive insights to proactively manage hemodynamic stability in high-acuity settings. This tool is ideal for anesthesiologists and critical care specialists aiming to prevent intraoperative hypotension or monitor patients with complex cardiovascular needs, leveraging machine learning to anticipate events up to 15 minutes in advance.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose Withings ECG App if…

Choose Withings ECG App if you are an individual seeking an accessible, over-the-counter solution for personal cardiovascular monitoring and early detection of atrial fibrillation. This app, paired with a compatible Withings ScanWatch, empowers users to record single-channel ECGs at home or on the go and easily share reports with their healthcare providers for ongoing management and peace of mind.

View Withings ECG App →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Withings ECG App
Pricing Contact-for-pricing Requires compatible withings device; withings app is free.
Deployment Integrated with Edwards Lifesciences HemoSphere Advanced Monitoring Platform (and previously EV1000 Clinical Platform) via dedicated sensors (Acumen IQ cuff or sensor). Mobile (iOS, Android)
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Withings ECG App

Tool B (Withings ECG App) is designed for over-the-counter use by general consumers, emphasizing intuitive mobile app interaction and integration with a wearable device. Tool A (Acumen HPI) is integrated into a complex clinical monitoring platform, requiring trained clinicians and specialized equipment, making it less broadly 'usable' for the general public.

Clinical Value

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A (Acumen HPI) offers predictive capabilities for acute, life-threatening hypotensive events up to 15 minutes in advance, providing critical insights for proactive clinical intervention in high-acuity settings. Tool B (Withings ECG App) provides valuable diagnostic information for cardiac arrhythmias like AFib, but its impact is more focused on detection and monitoring rather than real-time prediction of acute physiological decompensation.

Pricing & Value

Withings ECG App

Tool B (Withings ECG App) offers transparent, consumer-friendly pricing, with the app being free and an optional premium subscription at a clear monthly or annual cost. Tool A (Acumen HPI) requires contacting for pricing, indicating a complex enterprise sales model with potentially significant capital expenditure, making its value proposition less transparent and accessible.

Enterprise Readiness

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A (Acumen HPI) is explicitly designed for integration with Edwards Lifesciences' HemoSphere Advanced Monitoring Platform, making it inherently ready for deployment within existing hospital infrastructure and clinical workflows in critical care settings. Tool B (Withings ECG App) is a consumer-grade mobile and wearable solution, and while data can be shared, it is not built for direct, real-time integration into hospital enterprise systems in the same manner.

Innovation

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A (Acumen HPI) demonstrates higher innovation by utilizing machine learning for real-time, predictive analytics of a complex and dynamic physiological state (hypotension) and offering insights into its underlying causes. Tool B (Withings ECG App) provides valuable accessibility to single-lead ECG recording and arrhythmia detection, but the core technology is more established, with its innovation primarily in consumer accessibility and integration into a wearable.

Support & Docs

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

As an enterprise-grade clinical platform deployed in critical care environments, Tool A (Acumen HPI) is expected to come with comprehensive professional support, dedicated training, and extensive documentation tailored for healthcare professionals and hospital IT staff. Tool B (Withings ECG App), being a consumer product, relies more on online resources, user manuals, and customer service, with premium 'cardiologist reviews' being a service rather than core product support.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform Withings ECG App
Tool Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform Withings ECG App
Company Edwards Lifesciences Withings
Core Functionality Predicts hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. Enables users to record single-channel ECGs, detect atrial fibrillation (AFib), sinus rhythm, and high heart rate, and share data with healthcare professionals.
Key Predictive/Detection Capability Predicts hypotension up to 15 minutes in advance using a machine learning-based algorithm, HPI Parameter (0-100 likelihood score), Smart Alerts. Single-lead ECG recording, Atrial Fibrillation (AFib) detection, Sinus rhythm detection, High heart rate detection (100-150 bpm).
Monitoring Type Continuous hemodynamic monitoring, Non-invasive (Acumen IQ cuff) and minimally-invasive (Acumen IQ sensor) options. Wearable (integrated with Withings ScanWatch devices), Over-the-counter (OTC) use.
Target Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and Withings ECG App.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI integrates with Edwards Lifesciences HemoSphere/EV1000 platforms, providing a real-time hypotension prediction score and hemodynamic insights to guide proactive interventions in acute care settings. The Withings ECG App is a mobile-based solution for patient-initiated single-channel ECG recordings, with data shareable as PDFs for physician review to aid in diagnosis and treatment planning for cardiovascular conditions.
Acumen HPI integrates with the Edwards Lifesciences HemoSphere platform, but direct EHR integration capabilities are not explicitly detailed in the provided information. In contrast, Withings Remote Patient Monitoring (RPM) solutions, which include the ECG App, integrate with virtually every EHR platform for seamless data synchronization, device ordering, and alerts management.
Acumen HPI uses a machine learning algorithm to predict hypotensive events up to 15 minutes in advance, with an internal validation showing 89% specificity and 90% sensitivity 10 minutes before an event. The Withings ECG App has demonstrated 99.7% sensitivity in classifying AFib and 99.8% specificity in classifying normal sinus rhythm in classifiable recordings during a clinical study.
For Acumen HPI, clinicians would need to learn to interpret the HPI score, Smart Alerts, Smart Trend, and Relationship View screens, which is likely manageable for staff already familiar with complex critical care monitoring. The Withings ECG App is designed for over-the-counter use by patients, implying a very low learning curve for basic operation, with physicians interpreting the single-lead ECGs based on existing clinical knowledge.
The description for Acumen HPI does not explicitly mention audit trail features for tracking data access or alert acknowledgments within the system. Withings Health Solutions builds audit reports to ensure RPM records are audit-proof and can automatically track time spent monitoring patient measurements for CMS-compliant billing reports.
Deploying Acumen HPI across multiple sites would involve integrating with existing Edwards Lifesciences HemoSphere or EV1000 platforms in each unit. Key considerations would include standardizing protocols, comprehensive staff training across sites, and ensuring consistent technical support and infrastructure compatibility.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or Withings ECG App

Backers

Who funded each tool's parent company.

Withings ECG App

AI Tool Finder
AI-powered search. Results may not be comprehensive.